Development and Initial Testing of a Modified UroVysion-Based Fluorescence In Situ Hybridization Score for Prediction of Progression in Bladder Cancer

Molecular Markers Increase Precision of the European Association of Urology Non–Muscle-Invasive Bladder Cancer Progression Risk Groups

(2018) Kim E.M. van Kessel et al.   CLINICAL CANCER RESEARCH

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

(2017) Sebastien Antoni et al.   EUROPEAN UROLOGY

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

(2017) Marko Babjuk et al.   EUROPEAN UROLOGY

Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer

(2017) J. Alfred Witjes et al.   EUROPEAN UROLOGY

Prospective evaluation of fluorescence in situ hybridization for diagnosing urothelial carcinoma

(2017) Tianhai Lin et al.   Oncology Letters

Long-term validation of a molecular progression-associated gene classifier for prediction of muscle invasion in primary non-muscle-invasive bladder cancer

(2017) Ho Won Kang et al.   Oncology Letters

Comparison of different concepts for interpretation of chromosomal aberrations in urothelial cells detected by fluorescence in situ hybridization

(2016) Johannes Mischinger et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline

(2016) Sam S. Chang et al.   JOURNAL OF UROLOGY

Recurrence and progression in patients with non-muscle invasive bladder cancer: Prognostic models including multicolor fluorescencein situhybridization molecular grading

(2014) Michele Lodde et al.   INTERNATIONAL JOURNAL OF UROLOGY

Copy number aberrations using multicolour fluorescencein situhybridization (FISH) for prognostication in non-muscle-invasive bladder cancer (NIMBC)

(2013) Hideyasu Matsuyama et al.   BJU INTERNATIONAL

The Value of the Preoperative FISH Test in Unscreened Bladder Cancer Patients with TUR Indications

(2012) S. V. Petrov et al.   PATHOLOGY & ONCOLOGY RESEARCH

Urovysion: Considerations on modifying current evaluation scheme, including immunophenotypic targeting and locally set, statistically derived diagnostic criteria

(2011) Gabor Pajor et al.   CYTOMETRY PART A

Modified UroVysion scoring criteria increase the urothelial carcinoma detection rate in cases of equivocal urinary cytology

(2011) Clément J R Huysentruyt et al.   HISTOPATHOLOGY

Automated signal pattern evaluation of a bladder cancer specific multiprobe-fish assay applying a user-trainable workstation

(2011) Gabor Pajor et al.   MICROSCOPY RESEARCH AND TECHNIQUE

Fluorescence In Situ Hybridisation in the Diagnosis of Upper Urinary Tract Tumours

(2010) Christine Mian et al.   EUROPEAN UROLOGY

Quantitative Fluorescence in Situ Hybridization and its Ability to Predict Bladder Cancer Recurrence and Progression to Muscle-Invasive Bladder Cancer

(2009) Benjamin R. Kipp et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

The Value of the UroVysion® Assay for Surveillance of Non–Muscle-Invasive Bladder Cancer

(2007) Sigurdur Gudjónsson et al.   EUROPEAN UROLOGY

Urinary Markers in Bladder Cancer

(2007) Olaf P.J. Vrooman et al.   EUROPEAN UROLOGY